Status:
UNKNOWN
Propofol and Remifentanyl Versus Midazolam and Fentanyl for Diagnostic Colonoscopy in Patients With Compensated Cirrhosis Child A-B
Lead Sponsor:
Ziv Hospital
Conditions:
Liver Disease
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
This is a prospective, randomized-controlled trial (RCT) comparing the use of Propofol and Remifentanyl and traditional sedation (Midazolam and Fentanyl) for diagnostic colonoscopies in patients with ...
Eligibility Criteria
Inclusion
- Consecutive patients older than 18 and younger than 75 years with cirrhosis defined by the presence of liver fibrosis at least F3 and higher in the METAVIR score or with established cirrhosis (Child Pugh A, B)
Exclusion
- Patients with significant cardiorespiratory disease i.e. advanced respiratory, renal and heart failure (ASA class III or higher except for patients with decompensate liver cirrhosis), obstructive sleep apnea.
- HCC
Key Trial Info
Start Date :
August 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 1 2012
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT01148277
Start Date
August 1 2011
End Date
February 1 2012
Last Update
April 6 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ziv medical center liver unit
Safed, Israel, Israel, 13100